This message was posted by a user wishing to remain anonymous
Hi,
I've been looking into IVD registration in China, after hearing that certain immunohistochemistry and in situ hybridization IVDs have apparently been downgraded from Class III to Class I, but am having trouble finding any detailed information.
So far my web searching has brought up just a single article, on ChinaMedDevice.com, that mentions "CFDA Circular No. 226 of 2017":
2018 CFDA Changes in IVD Product ClassificationI've not yet been able to find that circular itself on the CFDA website, nor anything else regarding changes to IVD classification.
Does anyone have any information that would be of use, please, regarding the actual classification changes and what would be required?
Thanks in advance.